AHR

AHR

USD

American Healthcare REIT Inc. Common Stock

$31.110-0.110 (-0.352%)

실시간 가격

부동산
REIT - Healthcare Facilities
미국

가격 차트

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$31.220

고가

$31.220

저가

$30.720

거래량

0.11M

기업 기본 정보

시가총액

4.9B

산업

REIT - Healthcare Facilities

국가

United States

거래 통계

평균 거래량

1.84M

거래소

NYQ

통화

USD

52주 범위

저가 $13.67현재가 $31.110고가 $31.609

AI 분석 리포트

마지막 업데이트: 2025년 4월 27일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

AHR: American Healthcare REIT Inc. Common Stock - What's Happening and What to Watch

Stock Symbol: AHR Generate Date: 2025-04-27 04:58:53

Let's break down what's been going on with American Healthcare REIT, looking at the latest news, how the stock price has moved, and what some predictions are saying.

Recent News Buzz: What's the Vibe?

The news flow around AHR lately seems generally positive, with a few key points standing out. We saw the company announce the date for its first quarter 2025 earnings report and conference call, which is standard procedure but important for investors waiting on financial results.

More interestingly, several Wall Street analysts have weighed in. Both Morgan Stanley and RBC Capital maintained their positive ratings ("Overweight" and "Outperform," respectively). Morgan Stanley even nudged their price target up slightly, from $36 to $37. While Keybanc also kept an "Overweight" rating, they did trim their price target just a bit, from $35 to $34. So, the expert view is mostly upbeat, seeing potential room for the stock to grow, even with one analyst being slightly less bullish on the exact target price.

Adding to the good news, the company declared its first quarter 2025 dividend of $0.25 per share. Getting paid a dividend is always a plus for shareholders, signaling the company is generating cash and returning some of it.

Putting it simply, the recent news paints a picture of a company that analysts generally like, is returning cash to shareholders, and is getting ready to report its latest financial performance.

Price Check: What's the Stock Been Doing?

Looking at the stock's journey over the past few months (the data provided covers late January through late April), it's been quite a ride. The price started in the high $20s, dipped a bit in February, but then saw a pretty strong climb through March, pushing into the $30-$31 range. It hit a peak around $30.78 on April 1st and has mostly traded between $29.50 and $31.50 since then, showing some volatility but holding onto those higher levels.

The last price point we have is $31.11 (as of April 25th). This is sitting right near the top of its recent trading range and is very close to its 52-week high of $31.609.

Now, what about the immediate future? An AI prediction model suggests the price might see a slight dip in the very near term – predicting 0.00% change today, followed by small decreases of -0.50% and -0.40% over the next couple of days.

So, the stock has shown good upward momentum recently, reaching levels not seen in a while, but the AI thinks it might cool off just a touch in the next day or two.

Outlook & Ideas: Putting It All Together

Considering the positive analyst sentiment and the dividend declaration alongside the stock's recent strong run-up to near its 52-week high, the situation looks somewhat mixed for immediate action. The news is good, suggesting underlying health and expert confidence. However, the price is already quite high, and the AI predicts a small pullback.

This combination might suggest a 'Hold' stance if you already own shares, or a 'Watch' approach if you're thinking of buying. Buying right at a recent peak, especially when an AI predicts a slight dip, carries a bit more risk.

  • Potential Entry Consideration: If you're looking to get in, waiting for that predicted slight dip could be one strategy. The provided recommendation data points to potential entry levels around $30.99 or $31.14, noting the current price is near a support level ($31.06). This suggests that even a small dip from the current $31.11 might still be considered a reasonable entry point by some models, especially if you believe the positive analyst outlook will drive the price higher over time. Watching for the stock to hold above that $31 level after any dip could be a signal.
  • Potential Exit/Stop-Loss Consideration: For managing risk, setting a stop-loss is always smart. The recommendation data suggests a potential stop-loss level at $29.72. This is below recent trading ranges and could be a point where you decide to cut losses if the stock takes a significant turn downwards, protecting your capital. On the upside, the data suggests a potential take-profit level around $31.73, which is just above the current price and near the 52-week high – a level where some might consider selling to lock in gains.

Company Context

It's worth remembering that American Healthcare REIT operates in the Healthcare Facilities sector. This means its business relies on owning and managing properties like medical buildings, senior housing, and skilled nursing facilities. News related to healthcare trends, regulations, or the aging population can be particularly important for this company's performance. The analyst ratings and dividend reflect their view on how well the company is navigating this specific market.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can change rapidly. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

관련 뉴스

Analyst Upgrades

Jefferies Initiates Coverage On American Healthcare REIT with Buy Rating, Announces Price Target of $37

Jefferies analyst Joe Dickstein initiates coverage on American Healthcare REIT with a Buy rating and announces Price Target of $37.

더 보기
Jefferies Initiates Coverage On American Healthcare REIT with Buy Rating, Announces Price Target of $37

AI 예측Beta

AI 추천

약세

업데이트 시간: 2025년 4월 28일 오전 11:00

약세중립강세

64.9% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
보통
트레이딩 가이드

진입점

$30.99

익절

$31.73

손절

$29.72

핵심 요소

PDI 6.1이(가) ADX 13.4과 함께 MDI 4.7 위에 있어 강세 추세를 시사합니다.
현재 가격이 지지선($31.06)에 매우 근접하여 강력한 매수 기회를 시사합니다.
거래량은 평균(18,739)의 4.1배로 극도로 강력한 매수 압력을 나타냅니다.
MACD 0.0279이(가) 신호선 0.0220 위에 있어 강세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기